Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1533 ARTÍCULOS , VIENDO DEL 601 AL 615

[(18)F]GE-180 PET Detects Reduced Microglia Activation After LM11A-31 Therapy in a Mouse Model of Alzheimer's Disease

James ML, Belichenko NP, Shuhendler AJ, Hoehne A, Andrews LE, Condon C, Nguyen TV, Reiser V, Jones P, Trigg W, Rao J, Gambhir SS, Longo FM.

Theranostics. 2017 Mar 24;7(6):1422-1436. doi: 10.7150/thno.17666. eCollection 2017.

Identification of a novel PSEN1 mutation (Leu232Pro) in a Korean patient with early-onset Alzheimer's disease and a family history of dementia

Park J, An SSA, Giau VV, Shim K, Youn YC, Bagyinszky E, Kim S.

Neurobiol Aging. 2017 Aug;56:212.e11-212.e17. doi: 10.1016/j.neurobiolaging.2017.04.012. Epub 2017 Apr 26.

The novel PSEN1 M84V mutation associated to frontal dysexecutive syndrome, spastic paraparesis, and cerebellar atrophy in a dominant Alzheimer's disease family

Gallo M, Frangipane F, Cupidi C, De Bartolo M, Turone S, Ferrari C, Nacmias B, Grimaldi G, Laganà V, Colao R, Bernardi L, Anfossi M, Conidi ME, Vasso F, Curcio SAM, Mirabelli M, Smirne N, Torchia G, Muraca MG, Puccio G, Di Lorenzo R, Piccininni M, Tedde A, Maletta RG, Sorbi S, Bruni AC.

Neurobiol Aging. 2017 Aug;56:213.e7-213.e12. doi: 10.1016/j.neurobiolaging.2017.04.017. Epub 2017 Apr 27.

Association between advanced glycation end-products and functional performance in Alzheimer's disease and mixed dementia

Drenth H, Zuidema SU, Krijnen WP, Bautmans I, van der Schans C, Hobbelen H.

Int Psychogeriatr. 2017 Sep;29(9):1525-1534. doi: 10.1017/S1041610217000886. Epub 2017 May 25.

Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD)

Nave S, Doody RS, Boada M, Grimmer T, Savola JM, Delmar P, Pauly-Evers M, Nikolcheva T, Czech C, Borroni E, Ricci B, Dukart J, Mannino M, Carey T, Moran E, Gilaberte I, Muelhardt NM, Gerlach I, Santarelli L, Ostrowitzki S, Fontoura P.

J Alzheimers Dis. 2017;58(4):1217-1228. doi: 10.3233/JAD-161309.

Bidirectional interactions between diabetes and Alzheimer's disease

Shinohara M, Sato N.

Neurochem Int. 2017 Sep;108:296-302. doi: 10.1016/j.neuint.2017.04.020. Epub 2017 May 24.

Multimodal PET Imaging of Amyloid and Tau Pathology in Alzheimer Disease and Non-Alzheimer Disease Dementias

Xia C, Dickerson BC.

PET Clin. 2017 Jul;12(3):351-359. doi: 10.1016/j.cpet.2017.02.005. Epub 2017 Apr 18.

Alzheimer Disease: Scientific Breakthroughs and Translational Challenges

Caselli RJ, Beach TG, Knopman DS, Graff-Radford NR.

Mayo Clin Proc. 2017 Jun;92(6):978-994. doi: 10.1016/j.mayocp.2017.02.011.

F-18 FDG and F-18 Tau PET in posterior cortical atrophy

Tripathi M, Bansal A, Baghel V, Kumar P, Bal C.

Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1779-1780. doi: 10.1007/s00259-017-3738-9. Epub 2017 Jun 6.

Adverse Events With Sustained-Release Donepezil in Alzheimer Disease: Relation to Body Mass Index

Lee C, Lee K, Yu H, Ryu SH, Moon SW, Han C, Lee JY, Lee YM, Kim SG, Kim KW, Lee DW, Kim SY, Lee SY, Bae JN, Jung YE, Kim JL, Kim BS, Shin IS, Kim YH, Kim BJ, Kang HS, Myung W, Carroll BJ, Kim DK.

J Clin Psychopharmacol. 2017 Aug;37(4):401-404. doi: 10.1097/JCP.0000000000000726.

Acute cholinergic syndrome in a patient with mild Alzheimer's type dementia who had applied a large number of rivastigmine transdermal patches on her body

Suzuki Y, Kamijo Y, Yoshizawa T, Fujita Y, Usui K, Kishino T.

Clin Toxicol (Phila). 2017 Nov;55(9):1008-1010. doi: 10.1080/15563650.2017.1329536. Epub 2017 Jun 8.

Alzheimer's disease: The state of the art in resting-state magnetoencephalography

Engels MMA, van der Flier WM, Stam CJ, Hillebrand A, Scheltens P, van Straaten ECW.

Clin Neurophysiol. 2017 Aug;128(8):1426-1437. doi: 10.1016/j.clinph.2017.05.012. Epub 2017 May 21.

Promoting the maintenance of satisfactory communication: strategies used by caregivers and medical staff with people suffering from Alzheimer's disease

Vachon M, Veilleux MC, Macoir J.

Geriatr Psychol Neuropsychiatr Vieil. 2017 Jun 1;15(2):185-195. doi: 10.1684/pnv.2017.0665.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias